BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36293099)

  • 1. Evolution of Influenza Viruses-Drug Resistance, Treatment Options, and Prospects.
    Smyk JM; Szydłowska N; Szulc W; Majewska A
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip.
    Si L; Bai H; Oh CY; Jin L; Prantil-Baun R; Ingber DE
    Microbiol Spectr; 2021 Oct; 9(2):e0025721. PubMed ID: 34523991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza virus resistance to antiviral therapy.
    van der Vries E; Schutten M; Fraaij P; Boucher C; Osterhaus A
    Adv Pharmacol; 2013; 67():217-46. PubMed ID: 23886002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of antiviral drug resistance markers among human influenza A viruses in the Eastern Mediterranean Region, 2005-2016.
    Moasser E; Moasser A; Zaraket H
    Infect Genet Evol; 2019 Jan; 67():60-66. PubMed ID: 30389548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral resistance in influenza viruses.
    Márquez Domínguez L; Márquez Matla K; Reyes Leyva J; Vallejo Ruíz V; Santos López G
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):16-23. PubMed ID: 38158694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance.
    Han J; Perez J; Schafer A; Cheng H; Peet N; Rong L; Manicassamy B
    Curr Med Chem; 2018; 25(38):5115-5127. PubMed ID: 28933281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods.
    Nguyen HT; Fry AM; Gubareva LV
    Antivir Ther; 2012; 17(1 Pt B):159-73. PubMed ID: 22311680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States.
    Bright RA; Shay DK; Shu B; Cox NJ; Klimov AI
    JAMA; 2006 Feb; 295(8):891-4. PubMed ID: 16456087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fitness of neuraminidase inhibitor-resistant influenza A viruses.
    Baranovich T; Webster RG; Govorkova EA
    Curr Opin Virol; 2011 Dec; 1(6):574-81. PubMed ID: 22440915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Implications of Antiviral Resistance in Influenza.
    Li TC; Chan MC; Lee N
    Viruses; 2015 Sep; 7(9):4929-44. PubMed ID: 26389935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.
    Van Poelvoorde LAE; Saelens X; Thomas I; Roosens NH
    Trends Biotechnol; 2020 Apr; 38(4):360-367. PubMed ID: 31810633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral resistance in influenza viruses: laboratory testing.
    Laplante J; St George K
    Clin Lab Med; 2014 Jun; 34(2):387-408. PubMed ID: 24856534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance in influenza viruses].
    Hungnes O; Dudman SG
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2601-6. PubMed ID: 19023375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations.
    Dong G; Peng C; Luo J; Wang C; Han L; Wu B; Ji G; He H
    PLoS One; 2015; 10(3):e0119115. PubMed ID: 25768797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza drug resistance.
    Pizzorno A; Abed Y; Boivin G
    Semin Respir Crit Care Med; 2011 Aug; 32(4):409-22. PubMed ID: 21858746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedging against antiviral resistance during the next influenza pandemic using small stockpiles of an alternative chemotherapy.
    Wu JT; Leung GM; Lipsitch M; Cooper BS; Riley S
    PLoS Med; 2009 May; 6(5):e1000085. PubMed ID: 19440354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance for antiviral resistance among influenza viruses circulating in Algeria during five consecutive influenza seasons (2009-2014).
    Ait-Aissa A; Derrar F; Hannoun D; Gradi EA; Scaravelli D; Bouslama Z
    J Med Virol; 2018 May; 90(5):844-853. PubMed ID: 29315673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Within-Host Evolution of Human Influenza Virus.
    Xue KS; Moncla LH; Bedford T; Bloom JD
    Trends Microbiol; 2018 Sep; 26(9):781-793. PubMed ID: 29534854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.